Development of substituted 2-(4-(sulfonyl)piperazin-1-yl)quinazoline molecular hybrids as a new class of antimalarials. [PDF]
Madhav H +9 more
europepmc +1 more source
Accessibility to antimalarials in Spanish hospitals: analysis of a national survey. [PDF]
Bretones-Pedrinaci JI +4 more
europepmc +1 more source
False-positive Malaria Rapid Diagnostic Tests are Prevalent Among Children Under 5 Years of Age in Uganda. [PDF]
Cassidy CA +6 more
europepmc +1 more source
Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study. [PDF]
Kaur H +8 more
europepmc +1 more source
Artemether-lumefantrine versus pyronaridine-artesunate for the treatment of malaria in patients with mild to moderate COVID-19 in Kenya and Burkina Faso: a randomised open-label trial (MALCOV). [PDF]
Tangara B +30 more
europepmc +1 more source
A Novel Antimalarial Agent that Inhibits Protein Synthesis in Plasmodium falciparum. [PDF]
Bravo P +16 more
europepmc +1 more source
Artemisinin-Based Combination Therapies in East Africa: A Systematic Review of Quality, Clinical Efficacy, and Regulatory Progress Towards Sustainable Malaria Control. [PDF]
Mekasha YT +5 more
europepmc +1 more source
Issues associated with malaria self-medication in sub-Saharan Africa: A systematic literature review and meta-analysis. [PDF]
Amaka JI +9 more
europepmc +1 more source
Congenital Malaria in Non-Endemic Settings: A Literature Review and Update on Diagnosis and Management. [PDF]
Patterson CA +4 more
europepmc +1 more source
Novel heterospirocyclic antimalarials with activity against artemisinin- and multidrug-resistant P. falciparum malaria. [PDF]
Theodoridis L +8 more
europepmc +1 more source

